Effect of Infertility on the Sexual Function of Couples State of the Art
Trends Endocrinol Metab. Author manuscript; available in PMC 2013 Jul 1.
Published in final edited form as:
PMCID: PMC3389568
NIHMSID: NIHMS374746
The endocrine furnishings of nicotine and cigarette smoke
Jesse Oliver Tweed
1Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
Stanley H. Hsia
oneDivision of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew Academy of Medicine and Science, Los Angeles, CA 90059, United states of america
Kabirullah Lutfy
iPartitioning of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University of Medicine and Scientific discipline, Los Angeles, CA 90059, U.s.a.
2Higher of Chemist's shop, Western University of Health Sciences, Pomona, CA 91766, U.s.a.
Theodore C. Friedman
1Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
Abstract
With a current prevalence of approximately 20%, smoking continues to impact negatively upon health. Tobacco or nicotine apply influences the endocrine arrangement, with important clinical implications. In this review we critically evaluate the literature concerning the bear upon of nicotine too as tobacco use on several parameters of the endocrine system and on glucose and lipid homeostasis. Accent is on the effect of smoking on diabetes mellitus and obesity and the consequences of smoking cessation on these disorders. Understanding the effects of nicotine and cigarettes on the endocrine organisation and how these changes contribute to the pathogenesis of various endocrine diseases volition allow for targeted therapies and more effective approaches for smoking cessation.
Keywords: nicotine, cigarettes, pituitary, hormones, hypogonadism, habit
Epidemiology of nicotine employ
Cigarette smoking is a major public health issue in both the US and worldwide placing an enormous brunt on the US economy. Approximately 20% (~60 meg) of Americans smoke [one]. In addition, in 2008 in the The states, approximately 88 million nonsmokers aged ≥3 years were exposed to second-hand smoke [2]. Previous declines in rates of tobacco use have stalled over the past 5 years [iii]. Cigarette smoking (beginning- and second-hand) and exposure to nicotine are associated with premature death from chronic diseases, economical losses to society, and a substantial public wellness brunt [4]. The Centers for Disease Command (CDC) estimate that, between the years 2000 and 2004, the average almanac productivity losses attributable to smoking were approximately $96.eight billion [4]. Tobacco use has remained a particular burden for those below the poverty line [five], thus contributing to some of the wellness disparities in the United states of america.
Even though notable progress has been made in raising sensation of cigarettes in relation to cardiovascular and lung diseases, much less is known about the endocrine effects of nicotine and smoking. The goal of this article is therefore to review the effects of nicotine (Box ane) and cigarette smoking on the endocrine system, past critically evaluating studies in both humans and fauna models, and to accost areas in need of farther research. Gaining a improve understanding of the furnishings of nicotine on the endocrine system and its subsequent touch upon the pathogenesis of various endocrine diseases will permit targeted therapies and provide useful information for the development of more effective approaches for smoking cessation.
The effects of smoking and nicotine on pituitary/ stop-organ endocrine systems (Figure 1 and Tabular array 1)
Effects of nicotine on hypothalamic–pituitary–stop organ axes. Schematic demonstrating the effects of acute and chronic nicotine /cigarette use on hypothalamic–pituitary–end organ axes. (a) Nicotine mediates its effects on the hormonal levels of cortisol and AVP at the level of the hypothalamus or in other brain regions. (b) Nicotine mediates its effects on hormonal levels T3/T4 via direct activation of its stop-organ target, the thyroid. Most astute information is from nicotine administration studies whereas chronic information is predominantly from studies on cigarette smokers. The level of regulation of other hormones is either at the pituitary or unknown. Information technology is of import to annotation that many of the effects of nicotine on hormones are not well-understood, and often we can only assess the finish upshot of observed changes in circulating hormone levels. Underlined text in italics indicates hormones originating from the posterior pituitary.
Table 1
Summary of the furnishings of acute and chronic nicotine use on the endocrine systems of rodents and humans
| Hormone | Acute | Chronic | Potential physiological outcome | Refs |
|---|---|---|---|---|
| Prolactin (PRL) | ↑ | ↓ | Fertility, sexual behavior, lactation | [6,7] |
| Thyroid hormones (T4/T3) | = | ↑ | Increased metabolism | [ix–xi] |
| ACTH/cortisol | ↑ | ↑ | Increased catabolism (breakdown of protein), increased ability to handle stress, altered immune response | [17,xix] |
| Estradiol | = | ↑ | Endometrial build-up | [35] |
| Testosterone | = | ↑ or ↑↓ | In women: irregular periods and problems with ovulation. In men: increased assailment | [32,33,35] |
| Growth hormone (GH)/IGF-one | ↑ | ↓ | Changes in anabolism (build-up of poly peptide) and cell proliferation, low nascency-weight neonates | [eight,39] |
| Vasopressin (AVP) | ↑ | = | Changes in blood pressure, serum sodium levels and cognition | [8,42] |
| β-Endorphin | ↑ | ↑↓ | Pain threshold, immune responses | [97–99] |
| POMC | ↑ | Suppressed ambition | [55,56] | |
| NPY | ↑ | ↑↓ | Increased appetite | [56,57] |
| Orexins | ↑ | Increased ambition | [56] | |
| Ghrelin | ↑↓ | Suppressed appetite | [59,60] | |
| Leptin | ↓ | Weight gain | [62] | |
| Insulin | ↓ | Increased energy expenditure, weight loss | [62] |
Brief overview of the endocrine system
The endocrine organisation is a group of glands that maintain torso homeostasis via the secretion of unlike hormones. Many of these hormones are regulated via various regulatory axes including the hypothalamic–pituitary–adrenal axis (HPA), the hypothalamic–pituitary–gonadal centrality (HPG), and the hypothalamic–pituitary–thyroid axis (HPT).
The HPA axis is activated with the release of corticotropin-releasing hormone (CRH) from the hypothalamus, typically in response to psychological or physical stress. CRH then stimulates the anterior pituitary to produce adrenocorticotropic hormone (ACTH), which activates the production of cortisol by the adrenal gland. Cortisol mediates the physiological effects of this centrality which include effects on the cardiovascular system, command of metabolic homeostasis, issue on connective tissue, modulation of the immune system, and effects on behavior and cognition. The HPG axis is activated past gonadotropin-releasing hormone (GnRH), which is released from the hypothalamus and so stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. FSH and LH stimulate the testes and ovaries to release sex hormones, estradiol in females and testosterone in males. The HPT axis is activated by thyrotopin-releasing hormone (TRH) that is secreted from the hypothalamus which then stimulates the release of thyroid-stimulating hormone (TSH) from the anterior pituitary. TSH induces the production and release of triiodothyronine (T3) and thyroxine (T4) from the thyroid gland.
Ii additional anterior pituitary hormones are prolactin (PRL), which is regulated by dopamine, and growth hormone (GH), which is in part is regulated by growth hormone releasing hormone (GHRH) secreted from the hypothalamus. PRL regulates lactation. GH has many physiological functions including stimulating growth, prison cell regeneration and promoting gluconeogenesis. Vasopressin and oxytocin (OT) are hormones released from the posterior pituitary gland.
Cigarettes and prolactin
PRL secretion from the anterior pituitary is primarily inhibited past dopamine. Acute cigarette smoke significantly increased PRL secretion and the increase in PRL levels correlated with increased plasma nicotine levels [vi]. When subjects smoked nicotine-free cigarettes, PRL levels were unchanged [6]. Significant increases in PRL levels in response to opioid blockade have also been observed [vii]. However, the response is significantly diminished in smokers, relative to nonsmokers [7]. Because dopamine inhibits PRL secretion, opioids increase dopamine secretion that results in an inhibition of PRL secretion. Therefore, these data suggest that smokers may have blunted opioid-mediated dopamine release or dysregulated interactions between dopamine and PRL [seven]. Because the importance of dopamine levels in nicotine addiction, dysregulation of dopamine-release may play a part in the mechanism of addiction associated with nicotine. In light of the stimulatory effects of nicotine on dopamine levels one would await a decrease in PRL secretion, given the inverse relation between dopamine and PRL. Decreased PRL levels are observed in long-term, only not astute smoking, mayhap due to desensitization of the nAChRs [8].
Cigarettes and the HPT axis
The HPT axis maintains thyroid hormone production and disruption of this centrality tin result in either hypothyroidism or hyperthyroidism. Serum TSH levels are lower, whereas T3 and T4 levels are higher, in smokers versus non-smokers [nine] and in both active smokers and passive smokers [10,11]. This suggests that in that location is a stimulatory effect of cigarette smoke exposure on thyroid hormone release, with resultant suppression of TSH. This may have important clinical relevance when making the already hard evaluation and management of smokers with subclinical hyperthyroidism. Multiple studies have shown that there is a lower prevalence of thyroid auto-antibodies in smokers compared with nonsmokers [11,12] and smokers have lower rates of hypothyroidism [xiii]. Still, these studies merely offer evidence of an association between smoking and lower rates of hypothyroidism, and exercise not provide confirmation on causality or potential mechanisms behind the association between smoking and decreased rates of hypothyroidism. One recent written report showed that discontinuation of smoking might increase the adventure of developing thyroid peroxidase (TPO) antibodies [14]. In patients with Graves' disease, smoking conspicuously worsens thyroid-associated ophthalmopathy (TAO) [xv]. The pathogenesis of TAO involves inflammation, excess product of glycosaminoglycans, and adipogenesis resulting in an increase in the volume of both the orbital fat connective tissues and the extraocular muscle bodies [sixteen]. Interestingly, in an in vitro model, cigarette smoke extract increased both glycosaminoglycan production and adipogenesis, presenting a possible machinery past which cigarette smoke worsens TAO [16].
Nicotine and cigarettes and the HPA axis
Studies conducted in rats illustrate that nicotine and smoking stimulate the HPA axis and proceed via a central mechanism to stimulate CRH and/or arginine-vasopressin (AVP) which then leads to the release of ACTH from the anterior pituitary [17]. Smoking acutely activates the HPA axis resulting in increased cortisol levels [half dozen,18], and nicotine is the principal component of tobacco responsible for the stimulation of the HPA axis [xix]. Some of the furnishings of smoking on the HPA axis are given in Box 2.
The part of stress in affecting the HPA axis and how this pertains to smoking habits is of import. Smokers cite stress-relief as ane of the major reasons for smoking [20]. Grunberg and Shafer postulated the mechanisms on why stress is associated with increased smoking equally follows: (a) smoking decreases stress levels because nicotine or another chemic in tobacco relieves some aspects of stress; (b) stress decreases the activity of nicotine, thereby resulting in increased nicotine cocky–assistants to achieve the levels of activity that occur in not–stressful circumstances; (c) stress decreases the availability of nicotine, precipitating withdrawal and resulting in subsequent increased tobacco use; (d) tobacco smoking (and nicotine) enhance cognitive functions which overcome the deleterious effects of stress on cognition [21]. Stress is one of the leading causes of smoking relapse [22,23]. Stress too potentiates the rewarding and reinforcing actions of smoking [22,24]. Alternatively, nicotine deprivation betwixt cigarettes involves withdrawal symptoms including irritability, frustration, poor concentration, indisposition, and restlessness, all of which may exacerbate stress [25] and atomic number 82 to peckish for connected nicotine apply. Employ of nicotine lozenges reduces affective withdrawal symptoms in dependent smokers who recently quit [26]. Interestingly, in dependent smokers who study that smoking helps cope with stress, smoking cessation is associated with lowering of stress [27]. Despite the acute effects smoking may have on perceived stress, overall it appears that smoking may worsen negative emotional states [27]. It is probable that this overall country of elevated stress in smokers, as measured by elevated resting cortisol, is a reflection of a dysregulated HPA axis.
Cigarette apply and the reproductive centrality
Cigarette smoking is associated with decreased fertility in both males and females [28,29]. Cigarette smoking as well has a pregnant negative effect on the clinical outcome of assisted reproduction treatment (ART) [xxx].
The data on the effects of cigarette smoking on testosterone levels in men are alien. A cross-sectional report including a total of 255 men failed to show any significant association between cigarette smoking and several markers of male reproductive hormones, including total, gratis and bioavailable testosterone, sexual activity-hormone-binding globulin (SHBG), LH and FSH [31]. By contrast, in a cross-sectional population-based study of 3427 men, Svartberg and Jorde constitute that men who smoked had significantly college levels of total and gratis testosterone, compared with men who never smoked, and that testosterone levels were correlated with the number of cigarettes smoked daily [32]. Furthermore, Wu and colleagues found that the total but not gratis testosterone, SHBG, and LH were too significantly higher in current smokers compared with nonsmokers [33]. The alien data on the furnishings of smoking on testosterone may make the evaluation of testosterone levels in smokers difficult. Information technology may skew the clinical evaluation of hypogonadism in men, and brand the diagnosis and management of hypogonadism in older men more difficult. Cigarette smoking is as well associated with erectile dysfunction and it was estimated that 23% of cases of erectile dysfunction tin exist attributed to smoking [34].
A cantankerous-sectional report conducted in postmenopausal women revealed that testosterone levels were higher in current smokers, compared with nonsmokers, and testosterone, estradiol and SHBG levels increased as the extent of cigarette exposure increased [35]. After women stopped smoking for ane year, levels of estradiol and full and free testosterone returned to those of nonsmokers [35]. Considering loftier testosterone is part of the polycystic ovarian syndrome (PCOS) that is associated with infertility, lack of ovulation, menstrual irregularities and insulin resistance, the resolution of hormonal changes following smoking cessation suggests that smoking cessation could aid ameliorate some of the PCOS-related complications.
String-blood levels of LH and FSH in maternal smokers were not significantly dissimilar between smokers and non-smokers [36]. However, placental estriol, human placental lactogen (HPL) and β-homo chorionic gonadotropin (β-HCG) negatively correlated with the number of cigarettes smoked per day [36]. These changes may be pregnant because these placental hormones may affect fetal brain development.
Cigarettes and the GH/insulin-similar growth gene (IGF-1) axis
Cigarette utilize in pregnancy is associated with intrauterine growth restriction (IUGR) [37]. Cord plasma concentrations of IGF-I and IGF binding protein-3 were lower in the babies of mothers who had smoked, and this may contribute to fetal IUGR [38]. This suggests that smoking might accept some attenuating effects on growth in babies equally a result of lower IGF-1. IGF-i was decreased in female person but not male fetuses of asthmatic mothers who smoked cigarettes [39]. A lower birth-weight of female person but not male neonates of mothers with asthma who smoked during pregnancy correlated with lower IGF-1 levels [39]. Unfortunately few data are available regarding the furnishings of smoking on IGF-one levels in men or women, although older information show that smoking acutely raises GH levels [8]. Based on the available literature on how smoking affects IGF-1 and GH in utero nosotros conclude that smoking cessation during pregnancy is a prudent measure and benign to the wellness and growth of the fetus.
Cigarettes, nicotine, AVP and OT
Tobacco smoke and nicotine interact with the hormones AVP and OT secreted from the posterior pituitary (neurohypophysis). Direct application of nicotine to rodent hypothalamic tissue was shown to increase AVP levels [40]. In humans, cigarette smoking increased plasma AVP [8] and OT [41] levels. Well-nigh interestingly, the responses of AVP and cortisol to smoking are highly correlated, suggesting that the cortisol response to smoking may be attributable to the AVP increase [42]. Significantly higher levels of OT receptor mRNA were found in preterm myometrial strips in human and rats receiving cigarette-smoke extract compared to control groups that did non receive the excerpt [43]. These results, in both rats and humans, suggest that smoking may be related to increased contractile sensitivity of preterm myometrium in response to OT, which leads to increased chance of preterm delivery in women who smoke during pregnancy [43].
Cigarette smoking and osteoporosis
The association between smoking and osteoporosis is well established [44] with increased hip fractures seen in smokers [45]. Calcium assimilation and vitamin D levels are lower in smokers [46], with variable reports on PTH levels [47,48]. In improver, cigarette smoking may reduce the efficacy of estradiol therapy in increasing os mass [49]. The literature in humans clearly shows a relation between smoking and osteoporosis, and smoking cessation efforts should help decrease the rate of osteoporosis in smokers.
Metabolic homeostasis and cigarettes/nicotine
Obesity
It has long been recognized that smokers by and large take reduced body-weight compared to nonsmokers [50], that smoking cessation leads to weight gain [50], and that weight loss recurs when cigarette smoking is resumed [51]. Studies have reported a U-shaped relation between body mass index (BMI) and number of cigarettes smoked [52], with weight gain in the heavy smokers that correlates positively with number of cigarettes smoked [53], maybe influenced by poorer lifestyle habits amongst heavy smokers [54].
The mechanisms that underlie this weight phenomenon are complex and involve multiple neurochemical pathways that govern hunger and satiety. Contempo studies in rodents have shown that nicotine suppresses ambition ultimately via the activation of melanocortin-iv receptors (MC4R) expressed on hypothalamic pro-opiomelanocortin (POMC) neurons [55,56] that signals satiety. However, animals studies institute that hypothalamic neuropeptide Y (NPY), a stiff orexigenic neuropeptide that increases food intake, may be enhanced (either acutely [56] or after 7 weeks of nicotine exposure [57]) or, conversely, suppressed afterwards 12 weeks of exposure [58]. Orexins, a family of hypothalamic hormones which besides heighten feeding, were found to increase following nicotine exposure, in rodents [56]. Data with regards to the gut peptide ghrelin that induces satiety are unclear, and information technology has been reported that ghrelin may [59] or may not [60] be afflicted acutely by cigarette exposure in habituated smokers. However, it may fall with smoking cessation [61], and information technology may also be acutely reduced by cigarette exposure of nonsmokers [60]. The levels of the fat-derived hormone, leptin, and its hypothalamic receptor OBRb [62] may be reduced with nicotine exposure [62] and increased with cessation in humans [61], and this might be related to the changes observed in weight post-obit nicotine exposure. Nicotine exposure also increases energy expenditure [fifty], which is reversible with nicotine withdrawal [63].
Prenatal smoking exposure studies take found an association with subsequent childhood obesity [64,65] and have too suggested boosted 'imprinting' mechanisms [66] that contribute to obesity in the child, occurring dose-dependently and even in association with paternal smoking (i.e. passive exposure) [67]. Fauna models have shown that nicotine-exposed neonates which accept experienced growth retardation in utero display 'catch-up' growth and an expansion of adipose stores when provided with calorie excess, and this contributes to insulin resistance and glucose intolerance afterwards in life [68]. An observed association betwixt maternal smoking and short stature in the child [67] might be consistent with this theory, but the role of depression nascency-weight in the pathogenesis of this phenomenon has been questioned [66].
In exercise, fear of weight gain may attenuate the adherence of patients to smoking cessation programs, especially amongst female person smokers [69]. Greater forbearance may be achieved with smoking cessation programs that are combined with a variety of weight loss interventions, at to the lowest degree in the short-term [70,71]; long-term efficacy is less certain [seventy,71], and adjunctive pharmacotherapies for smoking cessation that as well benumb weight gain appear to exist more than effective than behavioral interventions alone [71]. Another related, troubling phenomenon in clinical practice is the use of cigarette smoking as an intentional means to lose weight [72].
Cigarette smoking/nicotine and insulin resistance and diabetes mellitus
Despite weight loss, cigarette exposure worsens insulin resistance [73], even with passive exposure, in a dose-dependent style [74], predisposing to the metabolic syndrome as a consequence [73]; alternatively, smoking cessation may also lead to changes that favor the development of insulin resistance, depending on the resulting variations in trunk weight [75]. Smoking is likewise associated with worsening visceral adiposity independently of changes in BMI [76], which helps explicate the paradox of increased metabolic risk associated with visceral adiposity, despite overall weight loss. Nevertheless, the incidence of metabolic syndrome may not be increased if weight loss is associated with a cyberspace loss of central adiposity [77]. Other potential mechanisms of nicotine-induced insulin resistance, born out of prison cell civilization, rodent and human studies, are listed in Box 3.
Studies have found that nicotine can dose-dependently reduce body-weight gain in mice that consume either a high-fat diet (HFD) or a normal chow nutrition, merely this effect is significantly greater in mice in the HFD group. Computed tomography analysis for fat distribution demonstrated that nicotine effectively reduced abdominal fat in mice that consumed the HFD, resulting in lower visceral fat [78]. The effect of nicotine on weight loss in mice on a HFD was completely blocked by mecamylamine, a nonselective nAChR adversary, merely was but partially blocked by the α4β2 nAChR fractional agonist/antagonist, varenicline, a drug known as Chantix that is currently used in the dispensary for smoking cessation [78].
Consistent with the adverse effects of nicotine on insulin sensitivity, at that place is a clear, dose-dependent relation betwixt diabetes or glucose intolerance and both active and passive cigarette exposure [79]. Notwithstanding, in keeping with the paradox of smoking-associated weight loss and greater insulin-resistance, some studies found that the amount of smoking interacts with BMI to produce either adverse or favorable effects on diabetes [80]. The incidence of diabetes may be lower with smoking if the weight loss leads to a net improvement in primal adiposity [77]. With smoking cessation, the take chances of diabetes decreases over time [81], simply it may also paradoxically increment in association with the weight gain that occurs during the first 3–5 years following smoking cessation [82].
Development of glucose intolerance requires damage of β jail cell role. Recent animal studies accept shown that prenatal nicotine exposure, which is toxic to β cell mitochondria and leads to apoptosis, impairs pancreatic islet development [66,68], thus limiting β jail cell reserve; however, in ane rat report, if nicotine exposure was not continued through both gestation and lactation, β cell recovery was still possible [83]. Maternal smoking during pregnancy has also been implicated in diabetes secondary to nonselective harm to the pancreas [84], and in clan with β cell car-antibodies, in young children [85].
In patients with established diabetes, nicotine exposure may paradoxically increment the incidence of astringent hypoglycemia in insulin-treated patients [86], perhaps via reduced clearance of subcutaneous insulin and enhancement of insulin action [87]. In addition, the kinetics of pulmonary absorption of inhaled insulin increase essentially in the smoking versus the nonsmoking state [88]. In diabetes care, smoking cessation is crucial to facilitating glycemic control and limiting the evolution of complications [23].
Smoking and fat liver
Non-alcoholic fat liver disease (NAFLD) and non-alcoholic steato-hepatitis (NASH) have emerged every bit important complications of insulin resistance. In humans, cigarette exposure is independently associated with ultrasound-defined NAFLD [89] likewise equally with avant-garde hepatic fibrosis [90], and fat liver synergizes with smoking in its clan with metabolic derangements [91]. In obese rats, the severity of NAFLD is worsened with long-term cigarette exposure, in clan with increased oxidative stress and apoptosis [92]. In a mouse model of nutrition-induced obesity, increased abdominal lipolysis coupled with exacerbation of hepatic steatosis [93] and increased skeletal muscle [94] fat accumulation was observed post-obit nicotine handling, This is of potentially serious clinical relevance because the clinical consequences of further progression of NASH and NAFLD to hepatic cirrhosis tin can be life-threatening.
Smoking and dyslipidemia
The dyslipidemia observed with cigarette smoking mirrors the archetype dyslipidemia of insulin-resistance that is characterized by elevated triglycerides (TG) and reduced high-density lipoprotein cholesterol (HDL-C) [95], with lesser effects on full and low-density lipoprotein cholesterol (LDL-C). Enzymes that attune this dyslipidemic contour, such every bit hepatic lipase and cholesterol ester transfer poly peptide, are involved in mediating these effects [95]. Favorable changes are seen with smoking cessation, particularly increased HDL-C [96]. These effects are closely associated with changes in insulin resistance, and probably contribute to the overall cardiovascular risks of smoking.
Concluding remarks
We have examined how nicotine exposure from smoking affects hormonal levels and metabolic homeostasis, using information from both humans and animal studies. The effect of smoking in thyroid affliction, osteoporosis, and lipid levels has also been discussed. With the loftier prevalence of smoking throughout the world and the growing burden of diabetes, smoking cessation of patients should be actively pursued equally function of prevention and management of diabetes regiments. All the same, the challenge of weight gain following smoking cessation remains, and this current review points out the impact of underlying hormonal changes, equally well as the psychological factors that are associated with this weight gain. Furthermore, as smoking by pregnant women continues, hormonal changes in response to nicotine exposure might gravely impact upon fetal health, and thus smoking abeyance is highly recommended.
Additional research is needed to tease out the differences between the effects of nicotine and cigarettes on the endocrine system and to decipher the physiological and clinical relevance of these hormonal changes; this information is defective in the electric current literature. In addition, the furnishings of 2d-hand smoke and of other forms of nicotine (nicotine replacement therapies such equally gums and patches, as well as chewless tobacco, Hookah, and electronic cigarettes) on the endocrine and metabolic systems as well need to be explored. Future studies should focus on providing useful information on the mechanisms of smoking-associated endocrine and metabolic diseases and give additional acceptance to smoking cessation.
Acknowledgments
This work was supported past a grant from the Minority Institutions' Drug Corruption Inquiry Evolution Program (MIDARP, grant R24DA017298).
References
ane. Garrett BE, et al. Cigarette smoking – United States, 1965–2008. MMWR Surveill Summ. 2011;60 (Suppl):109–113. [PubMed] [Google Scholar]
two. Vital signs: nonsmokers' exposure to secondhand smoke –United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2010;59:1141–1146. [PubMed] [Google Scholar]
3. Substance Abuse and Mental Health Services Assistants: Office of Applied Studies. NSDUH Series H-34, DHHS Publication No SMA 08-4343. 2008. Results from the 2007 National Survey on Drug Use and Wellness: National Findings. [Google Scholar]
4. Center for Disease Control and Prevention. Cigarette smoking amongst adults – United states of america 2007. MMWR. 2008;57:1221–1226. [PubMed] [Google Scholar]
five. Centers for Affliction Control and Prevention. Vital signs: current cigarette smoking amongst adults aged > or = 18 years – United States, 2009. Morb Mortal Wkly Rep. 2010;59:1135–1140. [PubMed] [Google Scholar]
6. Xue Y, et al. Venous plasma nicotine correlates of hormonal effects of tobacco smoking. Pharmacol Biochem Behav. 2010;95:209–215. [PMC complimentary article] [PubMed] [Google Scholar]
seven. Shaw D, al'Absi M. Blunted opiate modulation of prolactin response in smoking men and women. Pharmacol Biochem Behav. 2010;95:i–5. [PMC free article] [PubMed] [Google Scholar]
8. Fuxe Chiliad, et al. Neuroendocrine actions of nicotine and of exposure to cigarette fume: medical implications. Psychoneuroendocrinology. 1989;xiv:nineteen–41. [PubMed] [Google Scholar]
ix. Asvold BO, et al. Association of serum TSH with high body mass differs between smokers and never-smokers. J Clin Endocrinol Metab. 2009;94:5023–5027. [PubMed] [Google Scholar]
10. Soldin OP, et al. Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid. 2009;19:817–823. [PMC gratis article] [PubMed] [Google Scholar]
11. Jorde R, Sundsfjord J. Serum TSH levels in smokers and non-smokers. The 5th Tromso study. Exp Clin Endocrinol Diabetes. 2006;114:343–347. [PubMed] [Google Scholar]
12. Pedersen IB, et al. Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population written report. Eur J Endocrinol. 2008;158:367–373. [PubMed] [Google Scholar]
13. Effraimidis G, et al. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur J Endocrinol. 2011;164:107–113. [PubMed] [Google Scholar]
14. Effraimidis One thousand, et al. Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab. 2009;94:1324–1328. [PubMed] [Google Scholar]
16. Cawood TJ, et al. Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metab. 2007;92:59–64. [PubMed] [Google Scholar]
17. Matta SG, et al. Nicotine elevates rat plasma ACTH by a primal mechanism. J Pharmacol Exp Ther. 1987;243:217–226. [PubMed] [Google Scholar]
18. Seyler LE, Jr, et al. The effects of smoking on ACTH and cortisol secretion. Life Sci. 1984;34:57–65. [PubMed] [Google Scholar]
19. Rohleder North, Kirschbaum C. The hypothalamic–pituitary–adrenal (HPA) axis in habitual smokers. Int J Psychophysiol. 2006;59:236–243. [PubMed] [Google Scholar]
20. McEwen A, et al. Motives for smoking and their correlates in clients attending End Smoking treatment services. Nicotine Tob Res. 2008;10:843–850. [PubMed] [Google Scholar]
21. Grunberg NE, Shafer ST. Stress, smoking, and 9/xi/01. Psychiatry. 2005;68:311–315. [PubMed] [Google Scholar]
22. McKee SA, et al. Stress decreases the ability to resist smoking and potentiates smoking intensity and advantage. J Psychopharmacol. 2011;25:490–502. [PMC free commodity] [PubMed] [Google Scholar]
23. Public Health Service. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Study of the Surgeon General. Department of Health and Homo Services, Public Health Service, Function of the Surgeon General; 2010. [Google Scholar]
24. Childs E, de Wit H. Effects of acute psychosocial stress on cigarette craving and smoking. Nicotine Tob Res. 2010;12:449–453. [PMC free commodity] [PubMed] [Google Scholar]
25. Paolini M, De Biasi M. Mechanistic insights into nicotine withdrawal. Biochem Pharmacol. 2011;82:996–1007. [PMC free article] [PubMed] [Google Scholar]
26. Shiffman S. Upshot of nicotine lozenges on melancholia smoking withdrawal symptoms: secondary analysis of a randomized, double-bullheaded, placebo-controlled clinical trial. Clin Ther. 2008;30:1461–1475. [PubMed] [Google Scholar]
27. Hajek P, et al. The effect of stopping smoking on perceived stress levels. Addiction. 2010;105:1466–1471. [PubMed] [Google Scholar]
28. Practise Committee of American Society for Reproductive Medicine. Smoking and infertility. Fertil Steril. 2008;90:S254–S259. [PubMed] [Google Scholar]
29. Gaur DS, et al. Booze intake and cigarette smoking: touch on of ii major lifestyle factors on male fertility. Indian J Pathol Microbiol. 2010;53:35–40. [PubMed] [Google Scholar]
xxx. Farhi J, Orvieto R. Influence of smoking on outcome of COH and IUI in subfertile couples. J Assist Reprod Genet. 2009;26:421–424. [PMC free article] [PubMed] [Google Scholar]
31. Halmenschlager M, et al. Evaluation of the effects of cigarette smoking on testosterone levels in adult men. J Sex activity Med. 2009;six:1763–1772. [PubMed] [Google Scholar]
32. Svartberg J, Jorde R. Endogenous testosterone levels and smoking in men. The fifth Tromso study. Int J Androl. 2007;30:137–143. [PubMed] [Google Scholar]
33. Wu FC, et al. Hypothalamic–pituitary–testicular axis disruptions in older men are differentially linked to historic period and modifiable adventure factors: the European Male person Aging Study. J Clin Endocrinol Metab. 2008;93:2737–2745. [PubMed] [Google Scholar]
34. Wu C, et al. The association of smoking and erectile dysfunction: results from the Fangchenggang Area Male person Wellness and Examination Survey (FAMHES) J Androl. 2012;33:59–65. [PubMed] [Google Scholar]
35. Brand JS, et al. Cigarette smoking and endogenous sex hormones in postmenopausal women. J Clin Endocrinol Metab. 2011;96:3184–3192. [PubMed] [Google Scholar]
36. Varvarigou AA, et al. Outcome of maternal smoking on cord blood estriol, placental lactogen, chorionic gonadotropin, FSH, LH, and cortisol. J Perinat Med. 2009;37:364–369. [PubMed] [Google Scholar]
37. Villalbà JR, et al. Maternal smoking, social course and outcomes of pregnancy. Paediatr Perinat Epidemiol. 2007;21:441–447. [PubMed] [Google Scholar]
38. Pringle PJ, et al. The influence of cigarette smoking on antenatal growth, birth size, and the insulin-like growth factor axis. J Clin Endocrinol Metab. 2005;90:2556–2562. [PubMed] [Google Scholar]
39. Clifton VL, et al. Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-similar growth factor axis. Growth Horm IGF Res. 2010;20:39–48. [PubMed] [Google Scholar]
40. McKlveen JM, et al. Sexually diergic, dose-dependent hypothalamic–pituitary–adrenal centrality responses to nicotine in a dynamic in vitro perfusion organisation. J Pharmacol Toxicol Methods. 2010;61:311–318. [PMC costless article] [PubMed] [Google Scholar]
41. Chiodera P, et al. Gamma-aminobutyric acid mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking. Metabolism. 1993;42:762–765. [PubMed] [Google Scholar]
42. Chiodera P, et al. Abnormal consequence of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. Clin Endocrinol. 1997;46:351–357. [PubMed] [Google Scholar]
43. Nakamoto T, et al. Cigarette smoke extract enhances oxytocin-induced rhythmic contractions of rat and homo preterm myometrium. Reproduction. 2006;132:343–353. [PubMed] [Google Scholar]
44. Dimai HP, Chandran M. Official Positions for FRAX(R) clinical regarding smoking from Joint Official Positions Development Briefing of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R) J Clin Densitom. 2011;14:190–193. [PubMed] [Google Scholar]
45. Jenkins MR, Denison AV. Smoking condition every bit a predictor of hip fracture risk in postmenopausal women of northwest Texas. Prev Chronic Dis. 2008;5:A09. [PMC free article] [PubMed] [Google Scholar]
46. Demand AG, et al. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women. Osteoporos Int. 2002;13:83–88. [PubMed] [Google Scholar]
47. Jorde R, et al. Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The 5th Tromso study. Eur J Endocrinol. 2005;152:39–45. [PubMed] [Google Scholar]
48. Rapuri PB, et al. Smoking and bone metabolism in elderly women. Os. 2000;27:429–436. [PubMed] [Google Scholar]
49. Bjarnason NH, et al. The influence of smoking on bone loss and response to nasal estradiol. Climacteric. 2009;12:59–65. [PubMed] [Google Scholar]
50. Audrain-McGovern J, Benowitz NL. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther. 2011;90:164–168. [PMC free commodity] [PubMed] [Google Scholar]
51. Mozaffarian D, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392–2404. [PMC free article] [PubMed] [Google Scholar]
52. Chiolero A, et al. Association of cigarettes smoked daily with obesity in a general adult population. Obesity (Silverish Spring) 2007;15:1311–1318. [PubMed] [Google Scholar]
53. Watari M, et al. A longitudinal report of the influence of smoking on the onset of obesity at a telecommunication visitor in Japan. Prev Med. 2006;43:107–112. [PubMed] [Google Scholar]
54. Chiolero A, et al. Clustering of take chances behaviors with cigarette consumption: A population-based survey. Prev Med. 2006;42:348–353. [PubMed] [Google Scholar]
55. Mineur YS, et al. Nicotine decreases nutrient intake through activation of POMC neurons. Science. 2011;332:1330–1332. [PMC free article] [PubMed] [Google Scholar]
56. Huang H, et al. Nicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences. J Neurophysiol. 2011;106:1191–1202. [PMC gratis article] [PubMed] [Google Scholar]
57. Chen H, et al. Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat nutrition in mice. Am J Physiol Endocrinol Metab. 2007;293:E1564–E1571. [PubMed] [Google Scholar]
58. Chen H, et al. Regulation of hypothalamic NPY past nutrition and smoking. Peptides. 2007;28:384–389. [PubMed] [Google Scholar]
59. Bouros D, et al. Smoking acutely increases plasma ghrelin concentrations. Clin Chem. 2006;52:777–778. [PubMed] [Google Scholar]
lx. Kokkinos A, et al. Differentiation in the short- and long-term effects of smoking on plasma total ghrelin concentrations betwixt male person nonsmokers and habitual smokers. Metabolism. 2007;56:523–527. [PubMed] [Google Scholar]
61. Lee H, et al. Increased leptin and decreased ghrelin level later smoking cessation. Neurosci Lett. 2006;409:47–51. [PubMed] [Google Scholar]
62. Al Mutairi SS, et al. Upshot of smoking addiction on circulating adipokines in diabetic and non-diabetic subjects. Ann Nutr Metab. 2008;52:329–334. [PubMed] [Google Scholar]
63. Hur YN, et al. High fatty diet altered the mechanism of energy homeostasis induced by nicotine and withdrawal in C57BL/half dozen mice. Mol Cells. 2010;30:219–226. [PubMed] [Google Scholar]
64. Ino T. Maternal smoking during pregnancy and offspring obesity: meta-analysis. Pediatr Int. 2010;52:94–99. [PubMed] [Google Scholar]
65. Oken Eastward, et al. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obesity. 2008;32:201–210. [PMC free article] [PubMed] [Google Scholar]
66. Bruin JE, et al. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010;116:364–374. [PMC free commodity] [PubMed] [Google Scholar]
67. Koshy G, et al. Dose response association of pregnancy cigarette smoke exposure, babyhood stature, overweight and obesity. Eur J Public Wellness. 2011;21:286–291. [PubMed] [Google Scholar]
68. Somm Eastward, et al. Prenatal nicotine exposure alters early on pancreatic islet and adipose tissue development with consequences on the control of trunk weight and glucose metabolism later in life. Endocrinology. 2008;149:6289–6299. [PubMed] [Google Scholar]
69. Klesges RC, et al. Factors associated with participation, attrition, and event in a smoking cessation programme at the workplace. Health Psychol. 1988;7:575–589. [PubMed] [Google Scholar]
70. Spring B, et al. Behavioral intervention to promote smoking cessation and foreclose weight gain: a systematic review and meta-assay. Addiction. 2009;104:1472–1486. [PMC complimentary article] [PubMed] [Google Scholar]
71. Parsons Air conditioning, et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2009:CD006219. [PubMed] [Google Scholar]
72. Potter BK, et al. Does a relationship exist between torso weight, concerns about weight, and smoking among adolescents?. An integration of the literature with an emphasis on gender. Nicotine Tob Res. 2004;half-dozen:397–425. [PubMed] [Google Scholar]
73. Chiolero A, et al. Consequences of smoking for body weight, trunk fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801–809. [PubMed] [Google Scholar]
74. Thiering Due east, et al. Prenatal and postnatal tobacco smoke exposure and evolution of insulin resistance in ten year former children. Int J Hyg Environ Health. 2011;214:361–368. [PubMed] [Google Scholar]
75. Inoue K, et al. Early furnishings of smoking abeyance and weight gain on plasma adiponectin levels and insulin resistance. Intern Med. 2011;50:707–712. [PubMed] [Google Scholar]
76. Berlin I. Smoking-induced metabolic disorders: a review. Diabetes Metab. 2008;34:307–314. [PubMed] [Google Scholar]
77. Onat A, et al. Prospective epidemiologic evidence of a 'protective' effect of smoking on metabolic syndrome and diabetes among Turkish women – without associated overall health benefit. Atherosclerosis. 2007;193:380–388. [PubMed] [Google Scholar]
78. Mangubat M, et al. Event of nicotine on torso composition in mice. J Endocrinol. 2012;212:317–326. [PMC gratuitous article] [PubMed] [Google Scholar]
79. Willi C, et al. Agile smoking and the take chances of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654–2664. [PubMed] [Google Scholar]
lxxx. Nagaya T, et al. Heavy smoking raises risk for type 2 diabetes mellitus in obese men; just, light smoking reduces the chance in lean men: a follow-up study in Japan. Ann Epidemiol. 2008;18:113–118. [PubMed] [Google Scholar]
81. Hur NW, et al. Smoking cessation and risk of type two diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil. 2007;14:244–249. [PubMed] [Google Scholar]
82. Yeh HC, et al. Smoking, smoking cessation, and adventure for blazon 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152:10–17. [PMC gratis article] [PubMed] [Google Scholar]
83. Bruin JE, et al. Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying disquisitional windows of exposure. J Endocrinol. 2007;194:171–178. [PubMed] [Google Scholar]
84. Maisonneuve P, et al. Impact of smoking on patients with idiopathic chronic pancreatitis. Pancreas. 2006;33:163–168. [PubMed] [Google Scholar]
85. Wahlberg J, et al. Asthma and allergic symptoms and type 1 diabetes-related autoantibodies in 2.v-yr-onetime children. Pediatr Diabetes. 2011;12:604–610. [PubMed] [Google Scholar]
86. Hirai Fe, et al. Severe hypoglycemia and smoking in a long-term blazon ane diabetic population: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Intendance. 2007;30:1437–1441. [PubMed] [Google Scholar]
87. Bott S, et al. Bear upon of smoking on the metabolic action of subcutaneous regular insulin in blazon two diabetic patients. Horm Metab Res. 2005;37:445–449. [PubMed] [Google Scholar]
88. Becker RH, et al. The upshot of smoking cessation and subsequent resumption on absorption of inhaled insulin. Diabetes Intendance. 2006;29:277–282. [PubMed] [Google Scholar]
89. Hamabe A, et al. Bear on of cigarette smoking on onset of nonalcoholic fatty liver illness over a 10-yr period. J Gastroenterol. 2011;46:769–778. [PubMed] [Google Scholar]
90. Zein CO, et al. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver illness. J Hepatol. 2011;54:753–759. [PMC gratuitous commodity] [PubMed] [Google Scholar]
91. Chiang PH, et al. Synergistic effect of fat liver and smoking on metabolic syndrome. World J Gastroenterol. 2009;15:5334–5339. [PMC free article] [PubMed] [Google Scholar]
92. Azzalini L, et al. Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology. 2010;51:1567–1576. [PubMed] [Google Scholar]
93. Mangubat Thousand, et al. Nicotine induces oxidative stress and exacerbates high fat diet (HFD)-induced hepatic steatosis in a mouse manner of diet-induced obesity. Endocrine Soc. 2011;93:OR04–OR01. [Google Scholar]
94. Shin CS, et al. Nicotine plus a high-fat diet leads to intramyocellular fatty deposition in a mouse model of diet-induced obesity. Am Diabetes Assoc. 2011;71:2633–PO. [Google Scholar]
95. Chelland Campbell S, et al. Smoking and smoking cessation –the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008;201:225–235. [PubMed] [Google Scholar]
96. Gepner Advert, et al. Furnishings of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J. 2011;161:145–151. [PMC free article] [PubMed] [Google Scholar]
97. Conte-Devolx B, et al. Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat. Life Sci. 1981;28:1067–1073. [PubMed] [Google Scholar]
98. Pomerleau OF, et al. Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology. 1983;81:61–67. [PubMed] [Google Scholar]
99. Seyler LE, Jr, et al. Pituitary hormone response to cigarette smoking. Pharmacol Biochem Behav. 1986;24:159–162. [PubMed] [Google Scholar]
100. Doolittle DJ, et al. The genotoxic potential of nicotine and its major metabolites. Mutat Res. 1995;344:95–102. [PubMed] [Google Scholar]
101. Hukkanen J, et al. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57:79–115. [PubMed] [Google Scholar]
102. Yildiz D. Nicotine, its metabolism and an overview of its biological effects. Toxicon. 2004;43:619–632. [PubMed] [Google Scholar]
103. Fowles J, Dybing East. Application of toxicological risk cess principles to the chemical constituents of cigarette smoke. Tob Command. 2003;12:424–430. [PMC complimentary article] [PubMed] [Google Scholar]
104. Tuesta LM, et al. Recent advances in agreement nicotinic receptor signaling mechanisms that regulate drug cocky-administration behavior. Biochem Pharmacol. 2011;82:984–995. [PMC free commodity] [PubMed] [Google Scholar]
105. Liu RH, et al. The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. J Pharmacol Exp Ther. 2004;310:52–58. [PubMed] [Google Scholar]
106. Dani JA, De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav. 2001;lxx:439–446. [PubMed] [Google Scholar]
108. Mendelson JH, et al. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic–pituitary–adrenal axis hormones and mood in men. Neuropsychopharmacology. 2008;33:749–760. [PubMed] [Google Scholar]
109. Rao U, et al. Contribution of hypothalamic–pituitary–adrenal activeness and ecology stress to vulnerability for smoking in adolescents. Neuropsychopharmacology. 2009;34:2721–2732. [PMC free commodity] [PubMed] [Google Scholar]
110. Buchmann AF, et al. Cigarette craving increases later a psychosocial stress exam and is related to cortisol stress response but not to dependence scores in daily smokers. J Psychopharmacol. 2010;24:247–255. [PubMed] [Google Scholar]
111. Nakanishi Northward, et al. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med. 2000;133:183–191. [PubMed] [Google Scholar]
112. Tatebe J, Morita T. Enhancement of TNF-alpha expression and inhibition of glucose uptake by nicotine in the presence of a costless fatty acid in C2C12 skeletal myocytes. Horm Metab Res. 2011;43:11–16. [PubMed] [Google Scholar]
113. Bergman BC, et al. Intramuscular lipid metabolism in the insulin resistance of smoking. Diabetes. 2009;58:2220–2227. [PMC free article] [PubMed] [Google Scholar]
114. Kawamoto R, et al. Serum high molecular weight adiponectin is associated with balmy renal dysfunction in Japanese adults. J Atheroscler Thromb. 2010;17:1141–1148. [PubMed] [Google Scholar]
115. Otsuka F, et al. Smoking abeyance is associated with increased plasma adiponectin levels in men. J Cardiol. 2009;53:219–225. [PubMed] [Google Scholar]
116. Wang X, et al. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance. Endocrinology. 2011;152:836–846. [PMC free article] [PubMed] [Google Scholar]
117. Lakhan SE, Kirchgessner A. Anti-inflammatory furnishings of nicotine in obesity and ulcerative colitis. J Transl Med. 2011;ix:129. [PMC free article] [PubMed] [Google Scholar]
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389568/
0 Response to "Effect of Infertility on the Sexual Function of Couples State of the Art"
Post a Comment